TABLE 2.
Meta-analysis of arrhythmia patients’ treatment with Cordyceps.
| Category | n | Participants, n (cases/controls) | Heterogeneity | SMD (95%CI) | Z-test |
|---|---|---|---|---|---|
| Ph I2 (%) | |||||
| Average heart rate | |||||
| Bradyarrhythmia | 2 | 142/130 | 0.92 0 | 1.10 (0.85–1.36) | z = 8.44; P z <0.00001 |
| Tachyarrhythmia | 2 | 110/108 | <0.00001 97 | −1.14 (−2.83 to 0.56) | z = 1.32; P z = 0.19 |
| Minimal heart rate | |||||
| Bradyarrhythmia | 2 | 142/130 | <0.00001 97 | 0.99 (−0.49–2.46) | z = 1.31; P z = 0.19 |
| Inflammation index | |||||
| Hs-CRP | 1 | 66/66 | NA NA | 2.86 (2.37–3.35) | z = 11.46; P z <0.00001 |
| IL6 | 1 | 66/66 | NA NA | 2.29 (1.84–2.73) | z = 10.15; P z <0.00001 |
| TNF | 1 | 66/66 | NA NA | 2.13 (1.70–2.56) | z = 9.72; P z <0.00001 |
P z <0.05 shows a significant association. CI, confidence interval; NA, not available; SMD, standardized mean difference; Ph, p-values.